RIvoraxaban in Mitral Stenosis

Clinical trial NCT03926156 · TERMINATED

Trial details

NCT number: NCT03926156
Sponsor: Rajaie Cardiovascular Medical and Research Center
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Mitral Stenosis Rheumatic Heart Disease Atrial Fibrillation Anticoagulant Adverse Reaction

Start date: 2019-05-22
Primary completion: 2021-05-22
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.